ABSTRACT. Two azoospermic dogs with high plasma estradiol-17β (E 2 ) levels were subcutaneously injected with an aromatase inhibitor (AI), 4-androstene-4-ol-3,17-dione, 2 mg every other day for 4 weeks. Before the AI treatment the plasma E 2 levels of the two dogs (21 and 22 pg/ml, respectively) were higher than those of 2 normal dogs (8.1 and 12.3 pg/ml), and they fell to 11-17 pg/ml between 1 and 4 weeks after the start of AI treatment. The plasma testosterone levels after the start of AI treatment had increased to 2.1-3.1 ng/ ml. A small number of sperm were detected in the semen of the two dogs between 3 and 6 weeks after the start of AI treatment. Th ese results indicate that the testicular function of infertile dogs with high plasma E 2 levels can be temporarily improved by AI therapy. KEY WORDS: aromatase inhibitor, azoospermia, canine.J. Vet. Med. Sci. 65(12): 1343-1345, 2003 A portion of the testosterone (T) produced by the testis is converted to estradiol-17β (E 2 ) by aromatase enzyme activity [11]. In the testes of many species [2,17], including dogs [3], the E 2 -secreting cells are the Sertoli cells and/or the Leydig cells [13,20]. In men [6,19] abnormally increased testicular E 2 production causes spermatogenic dysfunction, and long-term E 2 administration has been shown to inhibit spermatogenesis in dogs [8,15]. Aromatase inhibitor (AI) blocks the aromatization of androgen to E 2 by inhibiting aromatase enzyme activity [1,18], and AI has been reported to be effective in treating spermatogenic dysfunction in men with high plasma E 2 levels [4]. In the present study, two azoospermic dogs with abnormally increased plasma E 2 levels were treated with AI to improve poor semen quality. Plasma E 2 levels after administration of follicle stimulating hormone extracted from porcine pituitary gland (FSH-P) were measured to investigate the main E 2 -secretory cells in canine testes.The two azoospermic dogs used to assess the effects of AI treatment were a Miniature Poodle (Dog 1) and a Beagle (Dog 2), aged 5 and 2 years, respectively. Dog 1 was owned by a breeder, and Dog 2 was cared for in our university. None of a few bitches mated with either of the two male dogs had conceived. Four semen specimens were collected by digital manipulation with a teaser bitch at one-week intervals. Each specimen was examine for total semen volume, total number of sperm, and morphologically abnormal sperm by the methods described previously [9]. As no sperm had been found in the semen of either Dog 1 or Dog 2 (Table 1), both of them were diagnosed as having azoospermia. Although the two azoospermic dogs were treated with 3 intramuscular injections of 1000 IU hCG per head at one-week intervals, their semen quality had failed to improve. Peripheral blood samples were collected from the two azoospermic dogs at the same time as the semen collections. Plasma E 2 and T levels were measured by the radioimmunoassay described previously [8]. The plasma E 2 levels of the two dogs (21 and 22 pg/ml, respectively) were higher than those o...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.